HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter A Merkel Selected Research
Peter A Merkel Research Topics
Disease
64
Vasculitis (Vasculitides)
02/2022 - 04/2002
57
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
05/2022 - 05/2007
42
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2022 - 09/2004
18
Microscopic Polyangiitis
01/2022 - 04/2003
16
Inflammation (Inflammations)
02/2022 - 07/2004
15
Churg-Strauss Syndrome (Allergic Angiitis)
05/2022 - 04/2003
12
Glomerulonephritis
01/2022 - 04/2011
9
Giant Cell Arteritis (Horton Disease)
01/2022 - 05/2002
8
Takayasu Arteritis (Arteritis, Takayasu's)
01/2022 - 07/2004
8
Systemic Scleroderma (Systemic Sclerosis)
02/2021 - 05/2005
7
Infections
01/2022 - 03/2005
6
Pain (Aches)
01/2022 - 09/2002
5
Hemorrhage
10/2020 - 07/2010
4
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 11/2013
4
Granuloma
01/2022 - 07/2004
4
Fatigue
01/2022 - 06/2008
4
Fibrosis (Cirrhosis)
01/2022 - 11/2006
4
Fever (Fevers)
01/2021 - 12/2011
4
Systemic Vasculitis
01/2018 - 04/2003
4
digital ulcers
05/2016 - 09/2002
4
Skin Diseases (Skin Disease)
04/2009 - 11/2006
3
COVID-19
01/2022 - 01/2021
3
Neoplasms (Cancer)
01/2022 - 05/2006
3
Sensorineural Hearing Loss
01/2022 - 12/2011
3
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 12/2011
3
Hypertension (High Blood Pressure)
01/2021 - 03/2007
3
IgA Vasculitis (Purpura, Schoenlein Henoch)
04/2020 - 01/2018
3
Arthritis (Polyarthritis)
04/2020 - 09/2002
3
Rheumatoid Arthritis
01/2020 - 04/2005
3
Pulmonary Arterial Hypertension
11/2015 - 11/2013
3
Telangiectasis (Telangiectasia)
06/2014 - 11/2013
3
Diffuse Scleroderma (Progressive Systemic Sclerosis)
02/2009 - 01/2007
2
Rare Diseases (Rare Disease)
05/2022 - 01/2016
2
Radiculopathy (Radiculopathy, Cervical)
01/2022 - 01/2022
2
Rheumatic Diseases (Rheumatism)
01/2022 - 01/2010
2
Shock
01/2022 - 01/2022
2
Macrophage Activation Syndrome
01/2022 - 01/2022
2
Hematuria
01/2022 - 01/2018
2
Mononeuropathies (Mononeuritis Multiplex)
01/2022 - 01/2022
2
Nasal Polyps (Nasal Polyp)
01/2022 - 01/2022
2
Aneurysm (Aneurysms)
01/2022 - 01/2022
2
Polyarteritis Nodosa (Periarteritis Nodosa)
04/2020 - 01/2020
2
Purpura
04/2020 - 04/2020
2
Seizures (Absence Seizure)
04/2020 - 11/2010
2
Weight Loss (Weight Reduction)
04/2020 - 06/2008
2
Proteinuria
01/2020 - 01/2018
2
Venous Thromboembolism
11/2019 - 01/2017
2
Peripheral Nervous System Diseases (PNS Diseases)
11/2019 - 07/2005
2
Asthma (Bronchial Asthma)
03/2019 - 01/2018
2
Weight Gain
04/2018 - 05/2008
2
Diabetes Mellitus
04/2018 - 07/2005
2
Herpes Zoster
06/2017 - 12/2005
2
Thrombosis (Thrombus)
01/2017 - 01/2009
Drug/Important Bio-Agent (IBA)
80
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
05/2022 - 04/2003
29
Rituximab (Mabthera)
FDA Link
01/2022 - 02/2009
23
Biomarkers (Surrogate Marker)
IBA
02/2022 - 05/2007
19
Glucocorticoids
IBA
10/2021 - 03/2005
19
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2020 - 05/2006
18
Myeloblastin (Proteinase 3)
IBA
01/2022 - 04/2003
12
Peroxidase (Myeloperoxidase)
IBA
01/2022 - 04/2003
12
Etanercept (Enbrel)
FDA Link
12/2016 - 07/2005
10
Azathioprine (Imuran)
FDA Link
Generic
04/2020 - 08/2013
7
Prednisone (Sone)
FDA Link
Generic
01/2021 - 07/2014
7
Creatinine
IBA
01/2021 - 12/2005
6
Antibodies
IBA
03/2017 - 05/2007
5
Pharmaceutical Preparations
IBA
02/2021 - 12/2011
5
Autoantibodies
IBA
01/2020 - 07/2011
4
C-Reactive Protein
IBA
01/2022 - 01/2016
4
Peptide Hydrolases (Proteases)
FDA Link
01/2022 - 01/2017
4
Acute-Phase Proteins (Acute-Phase Protein)
IBA
01/2022 - 01/2015
4
Proteins (Proteins, Gene)
FDA Link
08/2021 - 08/2013
4
Biological Products
IBA
06/2021 - 03/2007
4
avacopan
IBA
01/2021 - 04/2020
4
Immunoglobulin G (IgG)
IBA
01/2020 - 12/2011
4
ametantrone (HAQ)
IBA
05/2008 - 09/2002
3
Antigens
IBA
11/2021 - 04/2003
3
Anaphylatoxin C5a Receptor
IBA
01/2021 - 04/2020
3
Immunoglobulin A (IgA)
IBA
04/2020 - 12/2011
3
Cytokines
IBA
03/2019 - 03/2005
3
Abatacept (Orencia)
FDA Link
01/2017 - 07/2014
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2011 - 07/2004
2
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2022 - 01/2022
2
Antirheumatic Agents (DMARD)
IBA
01/2022 - 01/2021
2
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2022 - 01/2022
2
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
01/2022 - 01/2017
2
Opioid Analgesics (Opioids)
IBA
10/2021 - 01/2020
2
Colchicine
FDA Link
Generic
04/2020 - 08/2003
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
04/2020 - 05/2002
2
Fc Receptors (Fc Receptor)
IBA
01/2020 - 12/2011
2
Blood Proteins (Serum Proteins)
IBA
01/2020 - 08/2013
2
N-phthaloylglutamic acid
IBA
01/2020 - 02/2014
2
Indicators and Reagents (Reagents)
IBA
01/2020 - 09/2004
2
Interleukin-6 (Interleukin 6)
IBA
12/2019 - 05/2015
2
Lipids
IBA
11/2019 - 12/2007
2
Chemokines
IBA
03/2019 - 12/2018
2
mepolizumab
IBA
01/2019 - 01/2017
2
Enzymes
IBA
01/2017 - 11/2007
Therapy/Procedure
27
Therapeutics
01/2022 - 04/2002
9
Remission Induction
10/2021 - 05/2006
5
Plasma Exchange
01/2022 - 04/2011